American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain s GSK and Germany s CureVac $740 ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

Bold, strategic branding is reshaping how law firms build reputation, attract talent, and stay competitive. Here’s how the ...

Contract Development and Manufacturing Organizations (CDMOs) have carved out a lucrative niche within the biopharma industry, ...

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...

A massive New York housing project is one step closer to breaking the ground. The New York City Council Land Use and Zoning ...

President Donald Trump's administration on Tuesday announced it would terminate 22 federal contracts for mRNA-based vaccines, ...

Health Secretary Robert F. Kennedy Jr. announced plans Tuesday to cancel $500 million in vaccine development projects. In a ...

(Reuters) -U.S. drugmaker Pfizer raised its full-year profit forecast on Tuesday after reporting better-than-expected results ...

This article explains how aluminum adjuvants work in vaccines, their proven safety record, and addresses common myths and ...

US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million ...